Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Target price


06.07.22 / Tradegate WKN: A2AA7B / Name: Axsome / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Axsome Therapeutics Inc Stock

Axsome Therapeutics Inc dominated the market today, gaining €1.40 (3.490%).
With 5 Buy predictions and 4 Sell predictions the community is currently undecided on Axsome Therapeutics Inc.
On the other hand, the target price of €21.00 is below the current price of €41.97 for Axsome Therapeutics Inc, so the potential is actually -49.964%.
Our community identified positive and negative aspects for Axsome Therapeutics Inc stock for the coming years. 4 users see the criterium "Worthwhile Investment for the next years" as a plus for the Axsome Therapeutics Inc stock. On the other hand our users think that "Customer and product portfolio" could be a problem in the future.

Pros and Cons of Axsome Therapeutics Inc in the next few years

W********* I********* f** t** n*** y****
M***** P*******
S********** s********
C******** o* t** e**********
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Axsome Therapeutics Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Axsome Therapeutics Inc 3.490% 20.086% 73.215% -24.269% 33.535% - -
Kala Pharmaceuticals -1.300% 3.317% -6.089% -92.032% -68.276% - -
Clovis Oncology Inc. -6.860% 30.772% 233.151% -54.785% -11.132% -83.502% -97.416%
Epizyme Inc. -1.380% 4.255% 185.437% -77.209% -34.463% - -


Sell Axsome Therapeutics Inc
Show more